Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation
Eleonora Terzi, W. Ray Kim, William Sanchez, Michael R. Charlton, Paul Schmeltzer, Gregory J. Gores, James C. Andrews, Thomas C. Smyrk, Julie K. Heimbach – 5 November 2014 – Transarterial chemoembolization (TACE) is a common treatment for patients with hepatocellular carcinoma (HCC) who are awaiting liver transplantation (LT). The aim of this study was to assess the impact of multiple TACE treatments on tumor necrosis, tumor recurrence, and survival in these patients.